Targeting cellular senescence prevents glucocorticoid-induced bone loss through modulation of the DPP4-GLP-1 axis
Main Authors: | Tiantian Wang, Lin Yang, Zejun Liang, Lin Wang, Feijing Su, Xiangxiu Wang, Xuanhe You, Chengqi He |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-021-00528-0 |
Similar Items
-
Bone Aging, Cellular Senescence, and Osteoporosis
by: Robert J Pignolo, et al.
Published: (2021-04-01) -
Choosing between GLP-1 Receptor Agonists and DPP-4 Inhibitors: A Pharmacological Perspective
by: Dominique Xavier Brown, et al.
Published: (2012-01-01) -
Cellular senescence in mice
by: Wang, Chunfang
Published: (2008) -
The effect of DPP-4-protected GLP-1 (7–36) on coronary microvascular function in obese adults
by: Malin Nilsson, et al.
Published: (2019-03-01) -
SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors in Diabetes and Microvascular Complications: A Review
by: Christopher El Mouhayyar, et al.
Published: (2020-01-01)